These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23885912)

  • 81. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Review of radiofrequency ablation for renal cell carcinoma.
    Hines-Peralta A; Goldberg SN
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6328S-34S. PubMed ID: 15448026
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of expandable electrodes in percutaneous radiofrequency ablation of renal cell carcinoma.
    Gulesserian T; Mahnken AH; Schernthaner R; Memarsadeghi M; Weber M; Tacke A; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):133-9. PubMed ID: 16837160
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Local thermal ablation of renal cell carcinoma.
    Feng B; Liang P
    Eur J Radiol; 2012 Mar; 81(3):437-40. PubMed ID: 21239130
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Percutaneous cryoablation of renal masses: impact of patient selection and treatment parameters on outcomes.
    Vricella GJ; Haaga JR; Adler BL; Dean Nakamoto ; Cherullo EE; Flick S; Ponsky LE
    Urology; 2011 Mar; 77(3):649-54. PubMed ID: 21185065
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Recurrent renal cell carcinoma following nephrectomy and ablation therapy: Radiology perspective.
    Ali O; Fishman EK; Kawamoto S
    Eur J Radiol; 2018 Oct; 107():134-142. PubMed ID: 30292257
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.
    Kavoussi N; Canvasser N; Caddedu J
    Curr Urol Rep; 2016 Aug; 17(8):59. PubMed ID: 27344458
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interventional management of a renal cell carcinoma by radiofrequency ablation with tagging and cooling.
    Mahnken AH; Penzkofer T; Bruners P; Günther RW; Brehmer B
    Korean J Radiol; 2009; 10(5):523-6. PubMed ID: 19721840
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Management and prevention of renal ablative therapy complications.
    Igor Pinkhasov G; Raman JD
    World J Urol; 2010 Oct; 28(5):559-64. PubMed ID: 20383639
    [TBL] [Abstract][Full Text] [Related]  

  • 91. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Will radio frequency ablation become "routine first line answer" for small renal masses?
    Chin JL
    J Urol; 2012 Apr; 187(4):1153-4. PubMed ID: 22335876
    [No Abstract]   [Full Text] [Related]  

  • 93. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
    Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
    World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Radiofrequency ablation used to treat select renal and adrenal tumors.
    Zuboy J
    Curr Treat Options Oncol; 2000 Jun; 1(2):93-4. PubMed ID: 12061373
    [No Abstract]   [Full Text] [Related]  

  • 95. Rendezvous technique following thermal ureteric injury after radiofrequency ablation in a solitary kidney.
    Doody O; Given MF; Harper M; Kavnoudias H; Thomson KR; Lyon SM
    J Vasc Interv Radiol; 2008 Jul; 19(7):1112-4. PubMed ID: 18589329
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Renal ablation: current management strategies and controversies.
    Zhong J; Wah TM
    Chin Clin Oncol; 2019 Dec; 8(6):63. PubMed ID: 31968983
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Intramural Hydrodissection of an Adherent Bowel Loop during Renal Tumor Cryoablation: Complication or Thermoprotection?
    Garnon J; Fuerstner M; Uri IF; Ramamurthy N; Hausegger K
    J Vasc Interv Radiol; 2018 Sep; 29(9):1294-1296. PubMed ID: 30146201
    [No Abstract]   [Full Text] [Related]  

  • 98. Upper-Urinary-Tract Effects After Irreversible Electroporation (IRE) of Human Localised Renal-Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Ablate-and-Resect Study.
    Wendler JJ; Pech M; Köllermann J; Friebe B; Siedentopf S; Blaschke S; Schindele D; Porsch M; Baumunk D; Jürgens J; Fischbach F; Ricke J; Schostak M; Böhm M; Liehr UB
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):466-476. PubMed ID: 28929209
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparison of radiofrequency ablation, cryoablation, and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneys.
    Nakada SY; Jerde TJ; Warner TF; Lee FT
    J Endourol; 2004 Jun; 18(5):501-6. PubMed ID: 15253832
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [One-stage cryoablation of two renal tumors].
    Rasner PI; Vasilyev AO; Govorov AV; Pushkar DY; Pushkarev AV; Shakurov AV; Tsiganov DI; Zherdev AA
    Khirurgiia (Mosk); 2019; (1):95-100. PubMed ID: 30789616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.